NASDAQ:NTEC - Intec Pharma Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$8.13 +0.22 (+2.78 %)
(As of 12/16/2018 01:47 PM ET)
Previous Close$8.13
Today's Range$7.65 - $8.24
52-Week Range$3.55 - $8.24
Volume499,828 shs
Average Volume414,354 shs
Market Capitalization$266.88 million
P/E Ratio-4.93
Dividend YieldN/A
Beta0.75

Analyst Ratings

Intec Pharma (NASDAQ:NTEC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Intec Pharma in the last 12 months. Their average twelve-month price target is $12.8750, suggesting that the stock has a possible upside of 58.36%. The high price target for NTEC is $16.00 and the low price target for NTEC is $8.50. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $12.8750$12.8750$13.60$13.60
Price Target Upside: 58.36% upside123.91% upside227.71% upside197.27% upside

Intec Pharma (NASDAQ:NTEC) Consensus Price Target History

Price Target History for Intec Pharma (NASDAQ:NTEC)

Intec Pharma (NASDAQ:NTEC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/10/2018HC WainwrightReiterated RatingBuy$16.00HighView Rating Details
12/2/2018OppenheimerSet Price TargetBuy$15.00HighView Rating Details
10/5/2018Roth CapitalInitiated CoverageBuy$8.50HighView Rating Details
3/26/2018Maxim GroupBoost Price TargetBuy ➝ Buy$8.00 ➝ $12.00MediumView Rating Details
2/28/2018LADENBURG THALM/SH SHInitiated CoverageBuy ➝ BuyMediumView Rating Details
9/21/2017CIBCReiterated RatingOutperform ➝ Outperform$10.00 ➝ $15.00MediumView Rating Details
(Data available from 12/16/2016 forward)
This page was last updated on 12/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel